ECG Spectral Analysis for Resuscitation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current resuscitation methods for cardiac arrest, particularly for Ventricular Fibrillation (VF), face challenges in determining the effectiveness of interventions like defibrillation and thrombolytic agents, leading to potential myocardial injury and inefficient treatment protocols.
Innovation Solution
A system that analyzes electrocardiogram (ECG) signals using spectral analysis to determine metabolic state metrics, such as Area of the Amplitude Spectrum (AMSA), to predict the success of defibrillation and guide the administration of thrombolytic agents, adjusting interventions based on changes in these metrics over time.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If defibrillation is applied to treat Ventricular Fibrillation, then the probability of restoring perfusing cardiac rhythm increases, but myocardial injury occurs due to the shock treatment
Solution Approach 1:
The system performs preliminary spectral analysis of the VF waveform to predict the likelihood of successful defibrillation before administering the shock. By calculating metrics such as the area of the amplitude spectrum and median frequency, the system determines whether defibrillation is likely to succeed, thereby avoiding unnecessary shocks that would cause myocardial injury without benefit
2Reliability
If defibrillation is applied early to treat Ventricular Fibrillation, then the probability of success increases, but unnecessary defibrillation attempts cause myocardial damage
Solution Approach 1:
The system continuously monitors the VF waveform characteristics and uses spectral analysis to provide feedback on the likelihood of successful defibrillation. This feedback mechanism allows the system to make informed decisions about whether to administer defibrillation, avoiding unnecessary treatments that would cause harm without achieving the desired therapeutic effect
3Reliability
If thrombolytic agents are administered during resuscitation, then treatment effectiveness may improve, but the timing and dosage optimization is difficult to determine
Solution Approach 1:
The system replaces complex clinical judgment and manual assessment with automated spectral analysis of the ECG signal. By using objective metrics derived from frequency domain transformation of the VF waveform, the system provides data-driven guidance for thrombolytic agent administration, simplifying the decision-making process while improving treatment precision
Data Source
Figure 1a
Figure 1b
Figure 2
AI summary
A system including a sensor interface coupled to a processor. The sensor interface is configured to receive and process an analog electrocardiogram signal of a subject and provide a digitized electrocardiogram signal sampled over a first time period and a second time period that is subsequent to the first time period. The processor is configured to receive the digitized electrocardiogram signal, to analyze a frequency domain transform of the digitized electrocardiogram signal sampled over the first and second time periods and determine first and second metrics indicative of metabolic state of a myocardium of the subject during the first and second time periods, respectively, to compare the first and second metrics to determine whether the metabolic state of the myocardium of the subject is improving, and to indicate administration of an intervention to the subject in response to a determination that the metabolic state is not improving.